MAP1LC3B and neoplasm: As shown in Fig. 5J, compared with the other groups, the cotreatment group demonstrated an increase in the tumor tissue necrotic area, as well as the most significantly decreased Ki67 expression level and the most significant increase in cleaved caspase-3 and LC3B expression.